[go: up one dir, main page]

WO2009134010A3 - Pharmaceutical composition using herbal extract for prevention and treatment of obesity and metabolic disorders - Google Patents

Pharmaceutical composition using herbal extract for prevention and treatment of obesity and metabolic disorders Download PDF

Info

Publication number
WO2009134010A3
WO2009134010A3 PCT/KR2009/001542 KR2009001542W WO2009134010A3 WO 2009134010 A3 WO2009134010 A3 WO 2009134010A3 KR 2009001542 W KR2009001542 W KR 2009001542W WO 2009134010 A3 WO2009134010 A3 WO 2009134010A3
Authority
WO
WIPO (PCT)
Prior art keywords
obesity
prevention
treatment
pharmaceutical composition
metabolic disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/001542
Other languages
French (fr)
Korean (ko)
Other versions
WO2009134010A2 (en
Inventor
이경희
이용오
김유선
조영석
홍준기
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yuyu Pharma Inc
Original Assignee
Yuyu Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuyu Pharma Inc filed Critical Yuyu Pharma Inc
Priority to CN2009801153374A priority Critical patent/CN102014944B/en
Publication of WO2009134010A2 publication Critical patent/WO2009134010A2/en
Publication of WO2009134010A3 publication Critical patent/WO2009134010A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/754—Evodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a composition using composite herbal extracts for prevention and treatment of obesity and metabolic disorder. More specifically, the invention provides a composition containing Evodiae Fructus, Imperatae Rhizoma, and Citrus unshiu Markovich for prevention and treatment of obesity and metabolic syndromes or syndrome X.
PCT/KR2009/001542 2008-04-29 2009-03-26 Pharmaceutical composition using herbal extract for prevention and treatment of obesity and metabolic disorders Ceased WO2009134010A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009801153374A CN102014944B (en) 2008-04-29 2009-03-26 Pharmaceutical composition using herbal extract for prevention and treatment of obesity and metabolic disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0039874 2008-04-29
KR20080039874A KR101511364B1 (en) 2008-04-29 2008-04-29 Herbal Extract Composition for Prevention or Treatment of Obesity and Metabolic Syndrome Using Herbal Extract

Publications (2)

Publication Number Publication Date
WO2009134010A2 WO2009134010A2 (en) 2009-11-05
WO2009134010A3 true WO2009134010A3 (en) 2009-12-23

Family

ID=41255515

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/001542 Ceased WO2009134010A2 (en) 2008-04-29 2009-03-26 Pharmaceutical composition using herbal extract for prevention and treatment of obesity and metabolic disorders

Country Status (3)

Country Link
KR (1) KR101511364B1 (en)
CN (1) CN102014944B (en)
WO (1) WO2009134010A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014208799A1 (en) * 2013-06-28 2014-12-31 재단법인 아산사회복지재단 Composition for preventing or treating fatty liver comprising evodiae fructus extract and alkaloid compound isolated therefrom as active ingredients
CN109288843A (en) * 2018-11-19 2019-02-01 青岛大学 The hypolipidemic effect of evodiamine
RU2727465C1 (en) * 2019-07-15 2020-07-21 Игорь Фёдорович Душкин Method of restorative treatment of patients with metabolic syndrome at sanatorium-and-spa stage
KR102873886B1 (en) * 2022-11-24 2025-10-28 주식회사 비케이바이오 Composition for the prevention, improvement or treatment of ovesity or dyslipidemia containing immature citrus peel extract as an active ingredient
KR20240080809A (en) 2022-11-30 2024-06-07 한국한의약진흥원 Bioconverted extract of Evodia rutaecarpa Bentham with increased anti-obesity activity and method for preparing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047209A1 (en) * 1996-06-12 1997-12-18 Kyowa Hakko Kogyo Co., Ltd. Lipid metabolism ameliorants
KR19990011833A (en) * 1997-07-25 1999-02-18 김이현 Pharmaceutical composition for the treatment of gynecological diseases and women's obesity and preparation method of the same
KR20050078601A (en) * 2004-02-02 2005-08-05 주식회사 유유 New herbal composition for treatment and prevention of obesity
WO2005072757A1 (en) * 2004-02-02 2005-08-11 Yuyu Inc. Imperatae rhizoma extract for treatment and prevention of obesity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070224299A1 (en) * 2006-03-23 2007-09-27 Talbot Shawn M Weight loss with citrus flavonoids

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047209A1 (en) * 1996-06-12 1997-12-18 Kyowa Hakko Kogyo Co., Ltd. Lipid metabolism ameliorants
KR19990011833A (en) * 1997-07-25 1999-02-18 김이현 Pharmaceutical composition for the treatment of gynecological diseases and women's obesity and preparation method of the same
KR20050078601A (en) * 2004-02-02 2005-08-05 주식회사 유유 New herbal composition for treatment and prevention of obesity
WO2005072757A1 (en) * 2004-02-02 2005-08-11 Yuyu Inc. Imperatae rhizoma extract for treatment and prevention of obesity

Also Published As

Publication number Publication date
KR101511364B1 (en) 2015-04-10
WO2009134010A2 (en) 2009-11-05
CN102014944A (en) 2011-04-13
KR20090114093A (en) 2009-11-03
CN102014944B (en) 2012-10-03

Similar Documents

Publication Publication Date Title
UA99685C2 (en) Compositions for preventing or improving gastrointestinal diseases
WO2009086049A3 (en) Synergistic sweetening compositions
WO2011029077A3 (en) Botanical extracts and flavor systems and methods of making and using the same
WO2011073437A3 (en) Bacteriocin- and prebiotic-based cosmetic or dermatological compositions
IL184312A0 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
WO2007131677A8 (en) Use of ginsenosides and extracts containing them
EP2205255B8 (en) Herbal compositions and methods for treating hepatic disorders
WO2009134010A3 (en) Pharmaceutical composition using herbal extract for prevention and treatment of obesity and metabolic disorders
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
PL2240193T3 (en) Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases
WO2011018763A8 (en) Combination of proanthocyanidins such as pycnogenol or grape seeds and centella asiatica for the treatment of cardiovascular disorders such as atherosclerosis
ZA200807359B (en) Extract of herbal and the composition containing the same
WO2010106433A3 (en) Herbal cleansing composition and method of preparing the same
WO2006025696A3 (en) Composition for suppressing cyclooxygenase and/or 5-lipoxygenase
MY148570A (en) Health supplement composition of sea cucumber
EP2003988A4 (en) Natural plant extract composition for prevention and recovery of hyperlipidemia and stroke, natural tea containing the same as active ingredient and method for preparing the natural tea
WO2008094054A3 (en) 6, 8-dichlorchroman-3-yl-l, 3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders
EP1845928A4 (en) Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis
WO2005049058A8 (en) Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases
WO2014015067A3 (en) Scirpusin a and scirpusin band anti-obesity potential thereof
WO2011074765A3 (en) Composition including fermented material for oriental medicine as an active ingredient for preventing and treating obesity or hyperlipidemia
EP2438924A4 (en) Pharmaceutical composition containing herbal extracts for preventing or treating nephritis
WO2010090423A3 (en) Composition comprising combined crude drug extract for preventing and treating hyperlipidemia and diabetic hyperlipidemia
WO2011019153A3 (en) Composition for preventing or treating arthritis, containing an extract of an herbal medicine mixture of schisandra chinensis baillon, scutellaria baicalensis and kalopanax pictus nakai as an active ingredient
BR112012009351A2 (en) method for the prevention or treatment of disorders, use of a solanum glaucophyllum plant extract, dietary or dietary composition, dietary supplement, food or supplement

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980115337.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09738917

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09738917

Country of ref document: EP

Kind code of ref document: A2